Aripiprazole for the Augmentation of Antidepressant Therapy

NCT01429831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Taiwan Otsuka Pharm. Co., Ltd